483
Octapharma Plasma IncOctapharma Plasma Inc – FDA 483, Dec 11, 2025
Record Details
An FDA inspection of Octapharma Plasma Inc. in Santa Fe Springs, CA, from December 8-11, 2025, identified a significant deficiency in the firm's standard operating procedures. The SOPs failed to include critical criteria for determining donor eligibility, specifically regarding accurate blood pressure measurement. This omission led to observed instances of noncompliance during donor screenings, potentially compromising the integrity of the donor screening process.
View Company Profile
ID · 98d4c67b-9fa0-41ea-b834-f9bef9f8d3a0
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.